Close
Nordic 9Nordic 9

Desentum (private company)

Finland desentum.fi
See something wrong or missing? Let us know
Offices:Espoo
Industry:BiotechPharma
Business model:B2B

Desentum is a research-oriented biopharmaceutical company specialized in developing novel types of allergen immunotherapy products that are based on switching the immune system's response to allergens from hypersensitivity to tolerance.

Investors: we tracked 5 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 28.58M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Desentum

Name Criteria
France AbolerIS Pharma
57%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Denmark Acesion Pharma
57%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Denmark NMD Pharma
57%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Sweden OxThera
57%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Spain Sanifit Therapeutics
57%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Denmark Synklino
57%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Denmark Cytoki Pharma
57%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
United Kingdom Causaly
57%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Germany Cardior Pharmaceuticals
57%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
United Kingdom PetMedix
57%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Top